MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 143 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,493,402 | -16.4% | 2,163,883 | +1.3% | 0.09% | -21.9% |
| Q1 2024 | $18,523,360 | -11.5% | 2,136,489 | -33.2% | 0.11% | -18.0% |
| Q4 2023 | $20,937,003 | -12.2% | 3,196,489 | +34.0% | 0.14% | -14.2% |
| Q3 2023 | $23,857,470 | -22.5% | 2,385,747 | -3.6% | 0.16% | -29.3% |
| Q2 2023 | $30,773,535 | +23.1% | 2,475,747 | +38.8% | 0.23% | +4.6% |
| Q1 2023 | $24,994,695 | +39.9% | 1,784,061 | +42.9% | 0.22% | +18.4% |
| Q4 2022 | $17,870,600 | -56.5% | 1,248,819 | -22.4% | 0.18% | -61.4% |
| Q3 2022 | $41,092,000 | +41.3% | 1,609,572 | +57.3% | 0.48% | +43.8% |
| Q2 2022 | $29,079,000 | -5.9% | 1,023,531 | +16.8% | 0.33% | -2.3% |
| Q1 2022 | $30,902,000 | +43.1% | 876,147 | +99.1% | 0.34% | +27.7% |
| Q3 2021 | $21,597,000 | +389.6% | 440,046 | +255.6% | 0.27% | +368.4% |
| Q1 2021 | $4,411,000 | -85.2% | 123,764 | -88.3% | 0.06% | -86.4% |
| Q4 2020 | $29,744,000 | – | 1,060,408 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $269,495,240 | 12.63% |
| 12 West Capital Management LP | 3,361,836 | $41,787,621 | 3.59% |
| Alpine Peaks Capital, LP | 329,424 | $4,094,740 | 2.87% |
| Roubaix Capital, LLC | 235,480 | $2,927,016 | 2.15% |
| Prosight Management, LP | 628,600 | $7,813,498 | 1.17% |
| Cannon Global Investment Management, LLC | 15,800 | $196,394 | 1.02% |
| Curi Wealth Management, LLC | 566,417 | $7,040,564 | 0.95% |
| Mesirow Institutional Investment Management, Inc. | 693,376 | $8,618,664 | 0.89% |
| BRAIDWELL LP | 1,804,700 | $22,432,421 | 0.73% |
| Connacht Asset Management LP | 39,031 | $485,155 | 0.66% |